Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D9MWL4
|
|||
Drug Name |
Faricimab
|
|||
Synonyms |
RO6867461; RG7716
Click to Show/Hide
|
|||
Drug Type |
Antibody
|
|||
Indication | Diabetic macular edema [ICD-11: 9B71.02] | Approved | [1] | |
Neovascular age-related macular degeneration [ICD-11: 9B78.3Z; ICD-9: 362.5] | Approved | [1] | ||
Company |
Roche/Genentech
|
References | Top | |||
---|---|---|---|---|
REF 1 | FDA Approved Drug Products from FDA Official Website. 2023. Application Number: 761235. | |||
REF 2 | Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases. Expert Opin Investig Drugs. 2021 Mar;30(3):193-200. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.